期刊
CRITICAL CARE
卷 19, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s13054-015-0737-8
关键词
-
资金
- Fresenius (Bad Homburg, Germany)
- Nestle (Vevey, Switzerland)
- Aguettant (Lyon, France)
- Baxter (Deerfield, IL, USA)
- B. Braun (Melsungen, Germany)
- Nutricia (Amsterdam, The Netherlands)
- Abbott (North Chicago, IL, USA)
- Baxter
- Danone (Paris, France)
- Fresenius
- Nestle
- Nutricia
- Abbott
- Fresenius Kabi
- B Braun, Cosmed (Rome, Italy)
- Novartis
- Nutricia-Numico
- Pfizer (New York, NY, USA)
- Solvay (Brussels, Belgium)
- Danone
- Grifols (Barcelona, Spain)
- GlaxoSmithKline (Brentford, UK)
The results of recent large-scale clinical trials have led us to review our understanding of the metabolic response to stress and the most appropriate means of managing nutrition in critically ill patients. This review presents an update in this field, identifying and discussing a number of areas for which consensus has been reached and others where controversy remains and presenting areas for future research. We discuss optimal calorie and protein intake, the incidence and management of re-feeding syndrome, the role of gastric residual volume monitoring, the place of supplemental parenteral nutrition when enteral feeding is deemed insufficient, the role of indirect calorimetry, and potential indications for several pharmaconutrients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据